Haig P. Bozigian, Chief Development Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 5,441 shares at $83.23 ($452K) on 2018-02-05, disclosed to the SEC on 2018-02-07.
Open-market sale of $452k NBIX by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.02 | 1,375 | $114K | 25.3% |
| 2 | $83.02 | 1,375 | $114K | 25.3% |
| 3 | $83.23 | 887 | $74K | 16.3% |
| 4 | $83.23 | 887 | $74K | 16.3% |
| 5 | $82.48 | 917 | $76K | 16.7% |
| Total | $83.00 avg | 5,441 |
| $452K |
| 100% |
| Filing → |
| NBIX | SELL | 2020-08-07 | $537K | — | Filing → |
| NBIX | SELL | 2020-05-14 | $14.2M | — | Filing → |
| NBIX | SELL | 2020-04-28 | $385K | — | Filing → |